Categories: world

European bursaries end the session in red when global equities become lower

Europe's main index for stock markets ended Thursday's session, after having gone a lot of today's trading, thanks to better…

Europe’s main index for stock markets ended Thursday’s session, after having gone a lot of today’s trading, thanks to better than expected business results.

But Europe could not see a turn lower in US stocks with technological and communications services.

What do the markets do?

The Pan-European Stoxx Europe 600

SXXP, -0.51%

was closed 0.5% at 361.67 while U.K.’s FTSE 100

UKX, -0.39%

slipped to close 0.4% down at 7,026.99, as Brexit’s concern continued to affect trade. For both reference values, it was the worst point and percentage decrease for one week.

Germany’s DAX 30

DAX, -1.07%

was 1.1% at the end of Thursday trading, read 11,589.21 points and France’s CAC 40

PX1, -0.55%

fell 0.6% to 5.116.79 through the closing clock.

Italy’s FTSE MIB Italy Index

[1945 -1.89%

ended 1.9% down at 19,087.53, with concern over its budget negotiations with the European Union.

euro

EURUSD, -0.3478%

Revenued $ 1,1470, compared to $ 1,1502 late Wednesday in New York. The British Pound

GBPUSD, -0.6405%

was meanwhile $ 1,3043 from $ 1,3114.

Read: With “no-deal” Brexit risk of upturn, analysts are uncertain about pounds

What drives the market?

Market participants pointed to strength in a new era of profit as a reason that European stock indexes were a bit higher earlier in the session. However, European stocks, which usually take clues from the US stock market, ended the day lower after US stocks became red led by technology and communications services names. In addition, it is about Britain’s continued efforts to free itself from the EU, which seems to have been delayed in the midst of a border death.

U.K. Prime Minister Theresa May on Wednesday at a closely supervised summit in Brussels suggested that she consider an extended transition period for Brexit, as the British leader failed to create a new trade and customs pact, as Britain will leave the EU in March. An extension could see that Britain remains under EU rules until 2021 or longer, according to reports.

A so-called “no-deal” scenario is increasingly likely that the President of the European Council, Donald Tusk, said earlier this week, saying he had “no reason for optimism”. It can not affect the euro area markets and sharp pivots in the British Pound.

At the same time, investors also watched discussions between anti-establishment 5 Star Movement and the right-wing league over a full draft budget law that will be sent to the Italian Parliament on Saturday but is expected to wreak havoc from EU officials because it would increase the country’s deficit and damage to EU tax rules. European Central Bank chief Mario Draghi was quoted as saying that those Member States that did not respect EU rules risked high costs for all, according to Reuters.

What do Strategians say?

“At the same time as in the euro area, in addition to Brexit, Italy’s spending plans are another worrying issue for traders who recently commented on EU officials, including European Commission President Jean-Claude Junker showed hope of a breakthrough,” wrote Christina Parthenidou, Investment Analyst at XM in a Thursday research memo.

Paris-based shares Carrefour SA

CA, + 9.34%

led pan-European winners and ended the session more than 9% higher after the supermarket company reported better than expected sales in the third quarter.

LM Ericsson AB

ERICB, + 6.18%

closed 6.2% after the Swedish telecom supplier invented an estimation of “momentum” for the 5G market.

Unilever PLC p

-0.93%

lower was lowered by 0.9% lower at the end of the day even when the manufacturer of Breyer’s glass and Dove shampoo sold more products at higher prices and contributed to deliver stronger sales growth for the third quarter .

Novartis AG

NOVN, + 1.90%

raised its prospect on Thursday and announced that it would acquire radioactive drug companies Endocyte Inc. .

ECYT, + 50.26%

in a deal worth $ 2.1 billion, Novarti’s latest effort to turn into a focused pharmaceutical company. Novartis shares increased 1.9%.

Provides critical information for the American trading day. Subscribe to MarketWatch’s free need to know newsletters. Sign up here.

Share
Published by
Faela